3D Global Biotech Inc. (TPEX:6808)
Taiwan
· Delayed Price · Currency is TWD 53.70
-1.40 (-2.54%)
Jul 4, 2025, 1:48 PM CST
3D Global Biotech Market Cap
3D Global Biotech has a market cap or net worth of 4.16 billion as of July 3, 2025. Its market cap has increased by 89.75% in one year.
Market Cap
4.16B
Enterprise Value
3.55B
Revenue
265.69M
Ranking
n/a
PE Ratio
41.15
Stock Price
53.70
Market Cap Chart
Since December 25, 2020, 3D Global Biotech's market cap has increased from 2.74B to 4.16B, an increase of 52.19%. That is a compound annual growth rate of 9.72%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 4, 2025 | 4.16B | -18.84% |
| Dec 31, 2024 | 5.13B | 371.49% |
| Dec 29, 2023 | 1.09B | -27.35% |
| Dec 30, 2022 | 1.50B | -30.09% |
| Dec 30, 2021 | 2.14B | -18.98% |
| Dec 31, 2020 | 2.64B | -3.35% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 208.61B |
| PharmaEssentia | 190.29B |
| Bora Pharmaceuticals Co., LTD. | 84.09B |
| Lotus Pharmaceutical | 58.89B |
| Polaris Group | 30.59B |
| Oneness Biotech | 30.03B |
| Center Laboratories | 26.82B |
| TaiMed Biologics | 24.85B |